List of Chapters/Sections(Table Of Content)
1 Biosimilar Drug Market Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Segment by Type
1.2.1 Global Biosimilar Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Biosimilar Drug Segment by Application
1.3.1 Global Biosimilar Drug Sales Comparison by Application: (2021-2027)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Global Biosimilar Drug Market Size Estimates and Forecasts
1.4.1 Global Biosimilar Drug Revenue 2016-2027
1.4.2 Global Biosimilar Drug Sales 2016-2027
1.4.3 Biosimilar Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Biosimilar Drug Market Competition by Manufacturers
2.1 Global Biosimilar Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biosimilar Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biosimilar Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biosimilar Drug Manufacturing Sites, Area Served, Product Type
2.5 Biosimilar Drug Market Competitive Situation and Trends
2.5.1 Biosimilar Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilar Drug Players Market Share by Revenue
2.5.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilar Drug Retrospective Market Scenario by Region
3.1 Global Biosimilar Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Biosimilar Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Biosimilar Drug Market Facts & Figures by Country
3.3.1 North America Biosimilar Drug Sales by Country
3.3.2 North America Biosimilar Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilar Drug Market Facts & Figures by Country
3.4.1 Europe Biosimilar Drug Sales by Country
3.4.2 Europe Biosimilar Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilar Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilar Drug Sales by Region
3.5.2 Asia Pacific Biosimilar Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biosimilar Drug Market Facts & Figures by Country
3.6.1 Latin America Biosimilar Drug Sales by Country
3.6.2 Latin America Biosimilar Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilar Drug Sales by Country
3.7.2 Middle East and Africa Biosimilar Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biosimilar Drug Historic Market Analysis by Type
4.1 Global Biosimilar Drug Sales Market Share by Type (2016-2021)
4.2 Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
4.3 Global Biosimilar Drug Price by Type (2016-2021)
5 Global Biosimilar Drug Historic Market Analysis by Application
5.1 Global Biosimilar Drug Sales Market Share by Application (2016-2021)
5.2 Global Biosimilar Drug Revenue Market Share by Application (2016-2021)
5.3 Global Biosimilar Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CP Guojian Pharma
6.1.1 CP Guojian Pharma Corporation Information
6.1.2 CP Guojian Pharma Description and Business Overview
6.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CP Guojian Pharma Biosimilar Drug Product Portfolio
6.1.5 CP Guojian Pharma Recent Developments/Updates
6.2 Biotech Pharma
6.2.1 Biotech Pharma Corporation Information
6.2.2 Biotech Pharma Description and Business Overview
6.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Biotech Pharma Biosimilar Drug Product Portfolio
6.2.5 Biotech Pharma Recent Developments/Updates
6.3 Celgen Pharma
6.3.1 Celgen Pharma Corporation Information
6.3.2 Celgen Pharma Description and Business Overview
6.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgen Pharma Biosimilar Drug Product Portfolio
6.3.5 Celgen Pharma Recent Developments/Updates
6.4 Henlius
6.4.1 Henlius Corporation Information
6.4.2 Henlius Description and Business Overview
6.4.3 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Henlius Biosimilar Drug Product Portfolio
6.4.5 Henlius Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amgen Biosimilar Drug Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Eli Lilly Biosimilar Drug Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz Biosimilar Drug Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Changchun High Tech
6.8.1 Changchun High Tech Corporation Information
6.8.2 Changchun High Tech Description and Business Overview
6.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Changchun High Tech Biosimilar Drug Product Portfolio
6.8.5 Changchun High Tech Recent Developments/Updates
6.9 Innovent
6.9.1 Innovent Corporation Information
6.9.2 Innovent Description and Business Overview
6.9.3 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Innovent Biosimilar Drug Product Portfolio
6.9.5 Innovent Recent Developments/Updates
7 Biosimilar Drug Manufacturing Cost Analysis
7.1 Biosimilar Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilar Drug
7.4 Biosimilar Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilar Drug Distributors List
8.3 Biosimilar Drug Customers
9 Biosimilar Drug Market Dynamics
9.1 Biosimilar Drug Industry Trends
9.2 Biosimilar Drug Growth Drivers
9.3 Biosimilar Drug Market Challenges
9.4 Biosimilar Drug Market Restraints
10 Global Market Forecast
10.1 Biosimilar Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilar Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biosimilar Drug by Type (2022-2027)
10.2 Biosimilar Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilar Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biosimilar Drug by Application (2022-2027)
10.3 Biosimilar Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilar Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biosimilar Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
